VEEV (veeva.com) Total Enterprise Value

Corporate company logo of veeva.com (VEEV)

This daily price chart for Veeva Systems Inc. (VEEV) reflects an enterprise value of 43660.68. The business is striving for dominance in the biomedical cloud software segment while expanding its influence into the cosmetics and chemical markets. A high degree of backend and code automation allows the company to scale its product without inflating headcount. Furthermore, the digital documentation format minimizes paper usage during drug trials.

VEEV Veeva Systems Inc: Enterprise Value in the range 11/23/2025 - 10/28/2026

Analytical breakdowns for Veeva Systems Inc.

- price and consensus price forecast:
Market Price Veeva Systems|VEEV - Analyst Consensus Forecast
- market capitalization data:
Market Value Veeva|VEEV - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Veeva|VEEV - Book Capitalization|Market Capitalization to Book Value veeva.com|VEEV - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital Veeva Systems Inc.|VEEV - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital veeva.com|VEEV - Company Debts|Debt to Book Value Veeva
Fundamental company valuation:VEEV (Veeva Systems)
Mass-produced product of veeva.com

An ethical corporate culture and the retention of top IT talent at Veeva Systems Inc. (VEEV) create high intrinsic business value, which is reflected in the enterprise value financial assessment. This indicator sums market capitalization and net debt to determine the actual cost of a full company buyout, where an increase in the metric signals an overpayment, while a decrease indicates a potentially undervalued asset.

Direct competitors

Total Enterprise Value Doximity Inc DOCS|HQY (HealthEquity Corp) - Enterprise Value|Waystar Corp (WAY) - Total Enterprise Value|CorVel Corporation (CRVL) - Real Price to Acquire Entire Company|priviahealth.com (PRVA) - Total Company Value|HURN: Enterprise Value|Company Buyout Price Certara Inc (CERT)|Real Price to Acquire Entire Company Omnicell Corp|Aggregate Business Value GoodRx Gold GDRX|Real Price to Acquire Entire Company Schrodinger, Inc.|phreesia.com - Value Adjusted for Debt and Cash|OMDA: Total Company Value|EVH - Real Price to Acquire Entire Company|Enterprise Value HSTM|Definitive Corp (DH) - Total Enterprise Value|Enterprise Value Consensus Cloud Solutions (CCSI)|Business Value agilonhealth.com (AGL)|Real Price to Acquire Entire Company Absci Corporation (ABSI)|Total Company Value So-Young International Inc (SY)|NRC: Enterprise Value|Total Enterprise Value USA Mobility SPOK|OPRX (OptimizeRx Corporation) - Enterprise Value|trubridge.com (TBRG) - Total Enterprise Value|Simulations Plus (SLP) - Real Price to Acquire Entire Company|SOPHiA GENETICS (SOPH) - Total Company Value|HCAT (Health Catalyst, Inc) - Enterprise Value|Enterprise Value CareCloud Corp (CCLD)|Research Solutions, Inc. (RSSS) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash DLHC (dlhcorp.com)|Total Company Value ONMD|SCNX - Company Buyout Price|HCTI (Healthcare Triangle Corp) - Real Price to Acquire Entire Company|ISPC: Total Enterprise Value|bullfrogai.com - Total Company Value|Company Buyout Price scworx.com|MSP Recovery (MSPR) - Real Price to Acquire Entire Company|Aggregate Business Value iCoreConnect Corp|TRxADE - Enterprise Value|Total Enterprise Value ORGS (Orgenesis Corporation)|R1 RCM - Total Company Value|sharecare.com - Real Price to Acquire Entire Company|Total Company Value STRM (Streamline Health)|Syra Health Corp (SYRA) - Company Buyout Price|Real Price to Acquire Entire Company apollomed.net AMEH|Model N Corporation (MODN) - Value Adjusted for Debt and Cash|NXGN: Enterprise Value